Daniel C. Janki - 01 Apr 2026 Form 4 Insider Report for DELTA AIR LINES, INC. (DAL)

Reporting relationship: EVP & Chief Operating Officer
Issuer ticker: DAL
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2026, 17:30:08 UTC
Prior SEC filing: 06 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Alan T. Rosselot as attorney-in-fact for Daniel C. Janki

Key filing fact

Daniel C. Janki filed Form 4 for DELTA AIR LINES, INC. (DAL) on 03 Apr 2026.

Key facts

This page summarizes Daniel C. Janki's Form 4 filing for DELTA AIR LINES, INC. (DAL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Apr 2026, 17:30.

Change

Previous filing in this sequence was filed on 06 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001778620 Primary reporting owner

Janki Daniel C.

Relationship: EVP & Chief Operating Officer
Address: C/O DELTA AIR LINES, INC., DEPT. 981, 1030 DELTA BLVD., ATLANTA
Signature: /s/ Alan T. Rosselot as attorney-in-fact for Daniel C. Janki
Signature date: 03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DAL transaction

Common Stock

Award

Transaction value
Shares: +5,550
Change %: +1.5%
Price
Shares after: 381,937
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Personnel & Compensation Committee of Delta's Board of Directors (the "Committee") granted Mr. Janki 5,550 shares of restricted common stock under Delta's 2026 long-term incentive program. The shares will vest pursuant to the terms of the award agreement. This grant was approved by the Committee and is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3(d)(1).